Reflections on a recent NEJM publication highlight the importance of identifying and addressing the pathologic process of venous hypertension for optimizing clinical improvement in chronic venous insufficiency.
July 23, 2025—AngioDynamics, Inc. announced the publication of results from the PRESERVE study, which assessed the safety and effectiveness of i
July 23, 2025—Imperative Care, Inc. announced the FDA 510(k) clearance of and first patient cases with its Zoom 7X catheter for aspiration throm
July 22, 2025—InterVene, Inc., a developer of interventional devices for venous inflow and outflow obstructions, announced that the first-in-hum
July 22, 2025—Arsenal Medical recently announced findings from the EMBO-02 clinical study evaluating NeoCast, the company’s next-generatio
July 22, 2025—Perfuze, an Ireland-based developer of catheters for interventional stroke care, recently announced preliminary results from the U
July 16, 2025—Piccolo Medical, Inc. announced it has received FDA 510(k) clearance to market its next-generation SmartPICC stylet and PM2+ syste
July 18, 2025—Varian, a Siemens Healthineers company, recently announced the European launch of its next-generation IntelliBlate microwave ablat
July 16, 2025—Medtronic announced that the first patient has been enrolled in PELE, the Peripheral Onyx Liquid Embolic clinical trial. The inves
July 16, 2025—Imperative Care, Inc. announced findings from a subanalysis of patients with M2 occlusions enrolled in the Imperative Trial treate
July 14, 2025—Getinge announced that its iCast covered stent system has received FDA premarket approval for a new indication. The iCast device i
